 |
HOME | |
|
ABOUT US | |
|
PRODUCTS | |
|
||
|
CONTACT US |
About Us > The Company
GluMetrics, Inc. is a medical device company focusing patented technology on a currently shifting paradigm in the care of critically ill patients.
Recent scientific evidence confirms that dramatic improvements in the clinical outcome of hospitalized Intensive Care Unit (ICU) patients can result from tight therapeutic control of blood glucose to normal ranges. These studies indicate that Tight Glycemic Control (TGC) of ICU patients may reduce mortality by as much as 40%* and significantly lower complication rates.
GluMetrics has developed GluCath™ to monitor blood sugar accurately, conveniently and continuously in a device specifically designed to meet the challenging needs of the ICU environment.
GluMetrics, through the development of GluCath™, will provide hospitals with affordable technology to realize the clinical and financial benefits of TGC.
GluMetrics, Inc. is a privately-held corporation not listed with the public markets and, as such, is not available to individual investors at this time.